We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Latest News
Brain Cancer Patients Living Longer After Personalized Vaccine Therapy
News

Brain Cancer Patients Living Longer After Personalized Vaccine Therapy

Patients are surviving twice as long with DCVax®-Brain as with other therapeutics.
Nanosyn and Amphora Discovery Announce Collaborative Agreement
News

Nanosyn and Amphora Discovery Announce Collaborative Agreement

Nanosyn will provide chemistry-based services to Amphora Discovery for multiple drug targets.
Isis-Rosetta Collaborate to Develop Micro-RNA Related Therapies
News

Isis-Rosetta Collaborate to Develop Micro-RNA Related Therapies

Research demonstrates therapeutic potential of microRNA as a drug target using antisense.
Qiagen and ActiveSight Sign Co-Marketing Agreement Targeting Protein Crystallography
News

Qiagen and ActiveSight Sign Co-Marketing Agreement Targeting Protein Crystallography

The agreement seeks to ease access to protein crystallization reagents and crystallographic services.
Roche to Pilot Linguamatics for Molecular Genomics Research
News

Roche to Pilot Linguamatics for Molecular Genomics Research

Linguamatics I2E will be deployed to help with a wide range of knowledge discovery tasks.
Amphion Portfolio Company WellGen Completes $3M Funding
News

Amphion Portfolio Company WellGen Completes $3M Funding

The capital will provide resources for WellGen to begin clinical studies under its Obesity and Inflammation Programmes.
Cherry Picking in Drug Discovery
News

Cherry Picking in Drug Discovery

The scientific community will be gathering from 8 to 11 May 2006 for the 9th MipTec in Basel.
ChemDiv to Provide the German National Compound Library
News

ChemDiv to Provide the German National Compound Library

The library will represent about 80% of compounds of the central compound library for basic research.
Biosite and FivePrime Announce Antibody Collaboration
News

Biosite and FivePrime Announce Antibody Collaboration

Biosite will provide FivePrime with Omniclonal® antibodies for selected targets to accelerate FivePrime's therapeutic research efforts.
LifeSpan and MBL Announce Multi-Year Licensing and Asset Agreement
News

LifeSpan and MBL Announce Multi-Year Licensing and Asset Agreement

MBLI will distribute antibodies to druggable gene targets that LifeSpan has developed and commercialized.
Advertisement